v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash Flows From Operating Activities:    
Net loss $ (4,512,642) $ (5,321,212)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on extinguishment of note payable (17,893) (41,920)
Loss on legal settlement 126,400
Non-cash interest expense - warrants (135,924) (144,661)
Warrant modification expense 1,100
Changes in operating assets and liabilities:    
Prepaid expenses 321,500 324,925
Other current assets 11,099 10,787
Accounts payable 421,677 786,727
Accrued compensation 166,978 72,774
Net Cash Used In Operating Activities (2,684,162) (2,347,891)
Cash Flows From Financing Activities:    
Proceeds from issuance of common stock and warrants 640,626
Proceeds from issuance of Series B Convertible Preferred Stock and warrants 1,151,000 799,918
Repayment of financing liability (48,548) (279,467)
Net Cash Provided By Financing Activities 2,736,590 2,147,429
Net Increase (Decrease) In Cash 52,428 (200,462)
Cash - Beginning of Period 22,203 222,665
Cash - End of Period 74,631 22,203
Supplemental Disclosures of Cash Flow Information:    
Interest
Income taxes 949
Non-cash investing and financing activities:    
Common stock issued in satisfaction of accrued compensation 45,000
Common stock issued in connection with payment of Series A, B, and C Convertible Preferred Stock dividends in-kind 1,393,523 1,208,362
Financing of Director and Officer insurance 321,500 321,500
Conversion of Series C Convertible Preferred Stock into common stock 133 753
Conversion of accrued expenses into note principal 413,018
Accrual of warrant obligations in connection with issuance of notes payable 40,167
Warrants issued in satisfaction of accrued warrant obligation (40,167)
Issuance of warrants in connection with the issuance of notes payable 200,403 143,009
Issuance of warrants in connection with the exchange of notes payable 12,107
Accrual of earned preferred stock dividends (1,375,188) (1,228,685)
Conversion of convertible notes payable and accrued interest into Series C Preferred Stock and common stock 104,910 866,720
Issuance of warrants in connection with issuance of Series B Preferred Stock 181,600
Bifurcation of embedded derivative liabilities in connection with issuance of Series B Preferred Stock 105,000
Bifurcation of embedded derivative liabilities in connection with issuance of Series C Preferred Stock 1,700
Bifurcation of embedded derivative liabilities in connection with issuance of Note payable 12,500
Extinguishment of note payable for common stock 58,080
Subscription receivable related to sale of Series B Convertible Preferred Stock 50,000
Common Stock [Member]    
Stock-based compensation:    
Stock-based compensation 254,214 375,791
Warrant [Member]    
Stock-based compensation:    
Stock-based compensation 34,210 69,555
Nonrelated Party [Member]    
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest expense 156,221 126,364
Change in fair value of derivative liabilities - related party (353,174) (10,900)
Changes in operating assets and liabilities:    
Accrued expenses (109,694) 152,357
Accrued interest 181,956 227,044
Cash Flows From Financing Activities:    
Proceeds from issuance of convertible notes payable 919,960
Proceeds from issuance of notes payable 449,965 30,000
Proceeds from advances payable 59,375
Repayment of notes payable (6,250)
Related Party [Member]    
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest expense 153,693 254,205
Change in fair value of derivative liabilities - related party (44,835)
Changes in operating assets and liabilities:    
Accrued expenses 58,000 58,000
Accrued interest 729,352 585,873
Cash Flows From Financing Activities:    
Proceeds from issuance of convertible notes payable 146,672 677,018
Proceeds from issuance of notes payable 250,000
Proceeds from advances payable 100,000
Repayment of notes payable $ (6,250)